Translate
Aclarion Inc
About
Aclarion Inc (NASDAQ:ACON) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
Apr 22 2026
Aclarion Announces $2.5 Million Stock Repurchase Plan
Apr 16 2026
Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
Apr 14 2026
Aclarion Receives Pinnacle Award for AI Innovation
Apr 8 2026
Aclarion Announces Agreement with Weill Cornell Medicine
Financials
Revenue
$75.73 K
Market Cap
$7.99 M
EPS
-13.34